DINUTUXIMAB

DINUTUXIMAB was reported 859 times

DINUTUXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT CRANIAL NERVE NEOPLASM 18 0.6923
1 HUMAN ANTI-MOUSE ANTIBODY INCREASED 1 0.5000
2 CENTRAL NERVOUS SYSTEM NEUROBLASTOMA 1 0.5000
3 NEUROBLASTOMA RECURRENT 89 0.4384
4 PUPILLOTONIA 2 0.4000
5 RETRO-ORBITAL NEOPLASM 18 0.3396
6 KIDNEY HYPERMOBILITY 1 0.2000
7 THALAMIC MICROHAEMORRHAGE 1 0.1667
8 NEUROBLASTOMA 56 0.1462
9 PROTEIN ALBUMIN RATIO DECREASED 3 0.1364
10 HUMAN ANTI-MOUSE ANTIBODY POSITIVE 2 0.1176
11 GUT DERIVED INFECTION 1 0.0909
12 MYXOMA 1 0.0714
13 CENTRAL NERVOUS SYSTEM MELANOMA 1 0.0625
14 PUNCTURE SITE ABSCESS 1 0.0556
15 PLATELET ANISOCYTOSIS 1 0.0435
16 CONGENITAL CENTRAL HYPOVENTILATION SYNDROME 1 0.0417
17 BRAIN STEM MICROHAEMORRHAGE 1 0.0357
18 RETROGRADE PORTAL VEIN FLOW 1 0.0323
19 PLEUROPARENCHYMAL FIBROELASTOSIS 3 0.0288
20 CITROBACTER SEPSIS 1 0.0250
21 NEURONE-SPECIFIC ENOLASE INCREASED 1 0.0233
22 EMOTIONAL DISORDER OF CHILDHOOD 1 0.0161
23 CAPILLARY LEAK SYNDROME 33 0.0159
24 CAPILLARY PERMEABILITY INCREASED 1 0.0154
25 GANGLIONEUROMA 1 0.0152
26 ANAPLASTIC LYMPHOMA KINASE GENE MUTATION 1 0.0152
27 ANTITHROMBIN III DECREASED 4 0.0147
28 PNEUMOCYSTIS TEST POSITIVE 1 0.0139
29 MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN 1 0.0139
30 NEUROGENIC BOWEL 3 0.0126
31 MYELITIS TRANSVERSE 17 0.0121
32 POST PROCEDURAL HYPOTENSION 1 0.0118
33 GROWTH DISORDER 3 0.0111
34 ADENOVIRUS TEST POSITIVE 1 0.0105
35 OSTEOSARCOMA METASTATIC 1 0.0105
36 FIBRIN DEGRADATION PRODUCTS INCREASED 3 0.0101
37 DELIRIUM FEBRILE 1 0.0096
38 BLOOD LACTATE DEHYDROGENASE DECREASED 3 0.0090
39 ABDOMINAL REBOUND TENDERNESS 1 0.0089
40 CLOSTRIDIAL SEPSIS 2 0.0083
41 BLOOD GROWTH HORMONE ABNORMAL 1 0.0082
42 PERIPORTAL OEDEMA 1 0.0080
43 NEUTRALISING ANTIBODIES 1 0.0079
44 SHORT STATURE 2 0.0076
45 DEVELOPMENTAL REGRESSION 1 0.0074
46 GENE MUTATION IDENTIFICATION TEST POSITIVE 3 0.0071
47 HYPOALBUMINAEMIA 55 0.0071
48 IIIRD NERVE DISORDER 1 0.0070
49 ENDOCARDITIS NONINFECTIVE 1 0.0067
50 SECONDARY AMYLOIDOSIS 1 0.0066
51 EPIPHYSES PREMATURE FUSION 2 0.0066
52 GASTRITIS BACTERIAL 3 0.0064
53 PNEUMOPERICARDIUM 1 0.0058
54 ACUTE MYELOID LEUKAEMIA REFRACTORY 1 0.0058
55 MULTISYSTEM INFLAMMATORY SYNDROME 1 0.0058
56 TRI-IODOTHYRONINE DECREASED 3 0.0057
57 TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 1 0.0055
58 METASTASES TO SPINE 18 0.0054
59 FUNGAEMIA 8 0.0051
60 BONE MARROW TOXICITY 6 0.0051
61 OPTIC ATROPHY 8 0.0049
62 RED BLOOD CELL TRANSFUSION 2 0.0049
63 THYROXINE DECREASED 3 0.0048
64 REFRACTORY CANCER 1 0.0047
65 HEARING AID USER 2 0.0047
66 CARDIAC MYXOMA 1 0.0046
67 PNEUMATOSIS 2 0.0045
68 CHYLOTHORAX 3 0.0042
69 POSTICTAL PARALYSIS 1 0.0041
70 ACCOMMODATION DISORDER 3 0.0041
71 RESPIRATORY TRACT INFECTION FUNGAL 2 0.0038
72 URETERIC STENOSIS 3 0.0037
73 COOMBS TEST POSITIVE 1 0.0037
74 AGONAL RESPIRATION 1 0.0035
75 HUMAN HERPESVIRUS 6 ENCEPHALITIS 1 0.0035
76 URINARY TRACT INFECTION FUNGAL 2 0.0035
77 FIBRIN D DIMER INCREASED 12 0.0034
78 PREMATURE MENOPAUSE 3 0.0032
79 OTOTOXICITY 6 0.0032
80 PUPILLARY REFLEX IMPAIRED 6 0.0032
81 WHITE BLOOD CELLS URINE POSITIVE 6 0.0032
82 DEVICE PROGRAMMING ERROR 1 0.0032
83 PNEUMONIA LEGIONELLA 5 0.0031
84 RED BLOOD CELL SCHISTOCYTES PRESENT 1 0.0031
85 HYPERMAGNESAEMIA 2 0.0031
86 ANTIBODY TEST POSITIVE 5 0.0030
87 PERIPHERAL MOTOR NEUROPATHY 4 0.0029
88 FLUID IMBALANCE 2 0.0028
89 PORTAL VENOUS GAS 1 0.0028
90 NERVE COMPRESSION 25 0.0027
91 HUMAN RHINOVIRUS TEST POSITIVE 1 0.0027
92 ANISOCORIA 1 0.0026
93 BLOOD FIBRINOGEN DECREASED 3 0.0026
94 PUPILS UNEQUAL 3 0.0026
95 CAPILLARY DISORDER 1 0.0026
96 OSTEOSARCOMA 1 0.0026
97 INTRACRANIAL TUMOUR HAEMORRHAGE 1 0.0026
98 ADRENAL GLAND CANCER 1 0.0026
99 THROMBOTIC MICROANGIOPATHY 25 0.0026
100 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 2 0.0025
101 PRODUCT USED FOR UNKNOWN INDICATION 3 0.0024
102 TRANSPLANTATION COMPLICATION 1 0.0024
103 INCORRECT DRUG ADMINISTRATION RATE 10 0.0023
104 PANCREATIC ATROPHY 1 0.0023
105 POSTRENAL FAILURE 1 0.0023
106 EYELID INFECTION 1 0.0023
107 FEEDING INTOLERANCE 1 0.0022
108 PROTEIN URINE 2 0.0022
109 LACRIMATION DECREASED 1 0.0021
110 PYELOCALIECTASIS 2 0.0021
111 HYPOREFLEXIA 4 0.0021
112 BLOOD BICARBONATE INCREASED 1 0.0021
113 KNEE DEFORMITY 3 0.0020
114 HYPOPERFUSION 2 0.0019
115 PHARYNGEAL MASS 1 0.0019
116 SCROTAL PAIN 1 0.0019
117 BRADYPNOEA 5 0.0019
118 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 4 0.0018
119 CARDIOTOXICITY 16 0.0018
120 MYDRIASIS 23 0.0018
121 TREATMENT DELAYED 3 0.0017
122 TRANSAMINASES ABNORMAL 1 0.0017
123 URINE OUTPUT DECREASED 15 0.0017
124 FEBRILE INFECTION 2 0.0017
125 HYPERTENSIVE ENCEPHALOPATHY 1 0.0017
126 GRUNTING 1 0.0017
127 PUPILLARY DISORDER 1 0.0016
128 CATARACT SUBCAPSULAR 1 0.0016
129 EYELID OEDEMA 19 0.0016
130 GAMMA-GLUTAMYLTRANSFERASE INCREASED 36 0.0016
131 HYPERVOLAEMIA 8 0.0016
132 VENOOCCLUSIVE DISEASE 4 0.0016
133 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 8 0.0016
134 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 15 0.0016
135 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
136 SEDATION COMPLICATION 4 0.0016
137 ANAL INFLAMMATION 1 0.0016
138 BODY HEIGHT BELOW NORMAL 1 0.0016
139 PLATELET TRANSFUSION 2 0.0016
140 TUMOUR PAIN 2 0.0015
141 LEUKOCYTOSIS 27 0.0015
142 HYPOPHOSPHATAEMIA 11 0.0015
143 PARANEOPLASTIC SYNDROME 1 0.0015
144 NEURODEVELOPMENTAL DISORDER 1 0.0015
145 GASTROINTESTINAL TOXICITY 7 0.0015
146 PAINFUL ERECTION 1 0.0015
147 LIVEDO RETICULARIS 3 0.0014
148 FACE OEDEMA 24 0.0014
149 PULMONARY TOXICITY 10 0.0014
150 HEMIANOPIA HOMONYMOUS 1 0.0014
151 HYPOXIA 48 0.0014
152 METASTASES TO LIVER 23 0.0013
153 MYELITIS 2 0.0013
154 METAPNEUMOVIRUS INFECTION 1 0.0013
155 BLOOD FIBRINOGEN INCREASED 1 0.0013
156 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
157 LEUKOCYTURIA 1 0.0012
158 DYSCHROMATOPSIA 1 0.0012
159 ASPARTATE AMINOTRANSFERASE INCREASED 64 0.0012
160 CANCER PAIN 3 0.0012
161 DEVICE RELATED INFECTION 18 0.0012
162 THERAPY PARTIAL RESPONDER 18 0.0012
163 TRANSFUSION REACTION 1 0.0011
164 CATHETER SITE PRURITUS 1 0.0011
165 CONJUNCTIVAL HYPERAEMIA 4 0.0011
166 CANDIDA SEPSIS 1 0.0011
167 VENOUS OCCLUSION 2 0.0011
168 TENDON INJURY 4 0.0011
169 DRUG TOLERANCE DECREASED 3 0.0011
170 MICROANGIOPATHY 1 0.0011
171 PROTHROMBIN LEVEL DECREASED 1 0.0011
172 HYPERBILIRUBINAEMIA 11 0.0011
173 HYPOPROTEINAEMIA 2 0.0011
174 HAEMODYNAMIC INSTABILITY 8 0.0010
175 CANCER SURGERY 1 0.0010
176 CLOSTRIDIUM DIFFICILE COLITIS 11 0.0010
177 ADENOVIRUS INFECTION 3 0.0010
178 MULTI-ORGAN DISORDER 2 0.0010
179 ALANINE AMINOTRANSFERASE INCREASED 62 0.0010
180 HYPERNATRAEMIA 5 0.0010
181 ANORECTAL DISORDER 2 0.0010
182 ANAPHYLACTOID REACTION 4 0.0010
183 CORONAVIRUS TEST POSITIVE 1 0.0010
184 EOSINOPHIL COUNT INCREASED 8 0.0010
185 METASTASES TO PLEURA 1 0.0010
186 EXOPHTHALMOS 2 0.0009
187 URINARY RETENTION 31 0.0009
188 OCULAR TOXICITY 1 0.0009
189 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
190 LOCALISED OEDEMA 4 0.0009
191 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
192 ACUTE LUNG INJURY 1 0.0008
193 PNEUMONIA INFLUENZAL 1 0.0008
194 MYELODYSPLASTIC SYNDROME 12 0.0008
195 RENAL TUBULAR INJURY 1 0.0008
196 RESPIRATORY DEPRESSION 10 0.0008
197 VENOOCCLUSIVE LIVER DISEASE 4 0.0008
198 CARDIAC DYSFUNCTION 3 0.0008
199 TRISOMY 21 1 0.0008
200 GLUCOSE URINE PRESENT 1 0.0008
201 NEOPLASM PROGRESSION 27 0.0008
202 SPINAL CORD COMPRESSION 3 0.0008
203 ENCEPHALITIS AUTOIMMUNE 1 0.0008
204 RESPIRATORY DISTRESS 21 0.0008
205 NEUTROPHIL COUNT DECREASED 31 0.0008
206 EXTRADURAL HAEMATOMA 1 0.0008
207 BRONCHIECTASIS 5 0.0007
208 EFFUSION 1 0.0007
209 RHONCHI 1 0.0007
210 VIRAEMIA 1 0.0007
211 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
212 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
213 PNEUMATOSIS INTESTINALIS 2 0.0007
214 METASTATIC NEOPLASM 3 0.0007
215 HORDEOLUM 3 0.0007
216 METASTASES TO LUNG 8 0.0007
217 BONE MARROW FAILURE 14 0.0007
218 C-REACTIVE PROTEIN INCREASED 25 0.0007
219 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
220 IMMUNOSUPPRESSION 6 0.0007
221 STRIDOR 2 0.0007
222 GENITAL PAIN 1 0.0007
223 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
224 PAPILLOEDEMA 3 0.0007
225 ADHESION 1 0.0007
226 SMALL CELL LUNG CANCER 1 0.0007
227 PALLOR 18 0.0007
228 PULMONARY HAEMORRHAGE 5 0.0006
229 URINE KETONE BODY PRESENT 1 0.0006
230 CARDIAC TAMPONADE 3 0.0006
231 BRONCHOSPASM 9 0.0006
232 HYPOKALAEMIA 29 0.0006
233 PNEUMONIA VIRAL 2 0.0006
234 SKULL FRACTURE 1 0.0006
235 INJECTION SITE INFLAMMATION 3 0.0006
236 PANCYTOPENIA 33 0.0006
237 OEDEMA 32 0.0006
238 BACTERAEMIA 7 0.0006
239 PUPIL FIXED 1 0.0006
240 MENTAL STATUS CHANGES 16 0.0006
241 SPLENIC INFARCTION 1 0.0006
242 SERUM FERRITIN INCREASED 3 0.0006
243 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
244 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
245 GENERALISED OEDEMA 7 0.0006
246 PNEUMOMEDIASTINUM 1 0.0006
247 NEURALGIA 13 0.0005
248 HYDRONEPHROSIS 4 0.0005
249 TUNNEL VISION 1 0.0005
250 PHOTOPHOBIA 10 0.0005
251 PROTEIN TOTAL DECREASED 2 0.0005
252 HUMAN HERPESVIRUS 6 INFECTION 1 0.0005
253 PULMONARY HYPERTENSION 11 0.0005
254 GRANULOCYTOPENIA 3 0.0005
255 PROTEINURIA 10 0.0005
256 NEUROLOGICAL SYMPTOM 3 0.0005
257 HEPATIC MASS 1 0.0005
258 TRAUMATIC LUNG INJURY 1 0.0005
259 SINUS BRADYCARDIA 5 0.0005
260 METABOLIC DISORDER 3 0.0005
261 OXYGEN SATURATION DECREASED 29 0.0005
262 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
263 RHINOVIRUS INFECTION 2 0.0005
264 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
265 GASTROINTESTINAL INFLAMMATION 4 0.0005
266 LYMPHOCYTE COUNT DECREASED 9 0.0005
267 UNDERWEIGHT 1 0.0005
268 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3 0.0005
269 BLOOD ALBUMIN DECREASED 4 0.0005
270 PYREXIA 172 0.0005
271 DEVICE RELATED SEPSIS 1 0.0005
272 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
273 LARYNGEAL OEDEMA 3 0.0005
274 HYPERURICAEMIA 2 0.0005
275 NEUTROPENIC COLITIS 1 0.0005
276 OLIGURIA 3 0.0005
277 BLOOD UREA INCREASED 8 0.0005
278 ASCITES 14 0.0005
279 HALLUCINATIONS, MIXED 2 0.0005
280 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
281 NEUROGENIC BLADDER 1 0.0005
282 ABNORMAL SENSATION IN EYE 2 0.0005
283 CLOSTRIDIUM TEST POSITIVE 1 0.0005
284 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
285 ILEUS PARALYTIC 2 0.0004
286 SUSPECTED OFF LABEL USE 2 0.0004
287 METASTASES TO MENINGES 1 0.0004
288 HAEMATOCRIT INCREASED 1 0.0004
289 BREAKTHROUGH PAIN 1 0.0004
290 NEUROLOGICAL DECOMPENSATION 1 0.0004
291 METHAEMOGLOBINAEMIA 1 0.0004
292 HYPOMAGNESAEMIA 6 0.0004
293 PULSE ABNORMAL 1 0.0004
294 PLATELET COUNT DECREASED 44 0.0004
295 HYPERCALCAEMIA 5 0.0004
296 TRANSAMINASES INCREASED 9 0.0004
297 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
298 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
299 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
300 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
301 ACIDOSIS 3 0.0004
302 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
303 SARS-COV-2 TEST POSITIVE 5 0.0004
304 AREFLEXIA 1 0.0004
305 TACHYPNOEA 5 0.0004
306 METASTASES TO BONE 6 0.0004
307 RHINALGIA 1 0.0004
308 SERUM SICKNESS 1 0.0004
309 NEUTROPHIL COUNT ABNORMAL 1 0.0004
310 SPEECH DISORDER DEVELOPMENTAL 1 0.0003
311 PERICARDIAL EFFUSION 8 0.0003
312 ELECTROLYTE IMBALANCE 4 0.0003
313 ABDOMINAL PAIN 80 0.0003
314 SEDATION 9 0.0003
315 HYPERTRIGLYCERIDAEMIA 2 0.0003
316 CREPITATIONS 1 0.0003
317 URINE ANALYSIS ABNORMAL 1 0.0003
318 BLOOD BILIRUBIN INCREASED 9 0.0003
319 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
320 BONE MARROW DISORDER 1 0.0003
321 THROMBOCYTOPENIA 37 0.0003
322 CRANIOCEREBRAL INJURY 1 0.0003
323 CHEST X-RAY ABNORMAL 1 0.0003
324 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
325 PORTAL HYPERTENSION 1 0.0003
326 CONJUNCTIVITIS 6 0.0003
327 BACTERIAL INFECTION 6 0.0003
328 HYPOCALCAEMIA 6 0.0003
329 NON-CARDIAC CHEST PAIN 1 0.0003
330 PNEUMOTHORAX 5 0.0003
331 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
332 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
333 VITAMIN D DEFICIENCY 3 0.0003
334 HYPOGAMMAGLOBULINAEMIA 2 0.0003
335 ANAEMIA 58 0.0003
336 OTITIS MEDIA 1 0.0003
337 HYPONATRAEMIA 17 0.0003
338 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
339 POTENTIATING DRUG INTERACTION 1 0.0003
340 BK VIRUS INFECTION 1 0.0003
341 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
342 WOUND DEHISCENCE 1 0.0003
343 NEOPLASM RECURRENCE 1 0.0003
344 HYPOTENSION 59 0.0003
345 SUDDEN CARDIAC DEATH 1 0.0003
346 BLOOD CREATININE INCREASED 19 0.0003
347 VENTRICULAR EXTRASYSTOLES 3 0.0003
348 RESPIRATORY FAILURE 21 0.0003
349 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
350 PETECHIAE 3 0.0003
351 SINUS TACHYCARDIA 4 0.0003
352 END STAGE RENAL DISEASE 5 0.0003
353 CATHETER SITE INFECTION 1 0.0003
354 ACUTE MYELOID LEUKAEMIA 4 0.0003
355 RESPIRATORY ACIDOSIS 1 0.0003
356 HAEMATOCRIT DECREASED 5 0.0003
357 BLEPHARITIS 1 0.0002
358 PLEURAL EFFUSION 15 0.0002
359 SECOND PRIMARY MALIGNANCY 2 0.0002
360 COAGULOPATHY 4 0.0002
361 TACHYCARDIA 21 0.0002
362 LIP OEDEMA 1 0.0002
363 EATING DISORDER 5 0.0002
364 RESPIRATORY DISORDER 7 0.0002
365 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
366 PSEUDOMONAS INFECTION 2 0.0002
367 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
368 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
369 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
370 ANAL INCONTINENCE 2 0.0002
371 VASCULAR DEVICE INFECTION 1 0.0002
372 DISEASE PROGRESSION 26 0.0002
373 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
374 BRAIN NEOPLASM 2 0.0002
375 SHOCK 5 0.0002
376 PAIN IN JAW 6 0.0002
377 HAEMATOTOXICITY 2 0.0002
378 PULSE ABSENT 1 0.0002
379 HYPOVOLAEMIC SHOCK 1 0.0002
380 RASH VESICULAR 1 0.0002
381 HYPOKINESIA 3 0.0002
382 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
383 GASTROENTERITIS 3 0.0002
384 LIVER INJURY 5 0.0002
385 HEPATOMEGALY 2 0.0002
386 WHEEZING 12 0.0002
387 INFLAMMATORY MARKER INCREASED 1 0.0002
388 BLADDER DISORDER 2 0.0002
389 IMMUNODEFICIENCY 3 0.0002
390 PROTEIN URINE PRESENT 1 0.0002
391 HYPOTONIA 2 0.0002
392 OSTEOPENIA 3 0.0002
393 BLINDNESS 8 0.0002
394 PRODUCT USE IN UNAPPROVED INDICATION 46 0.0002
395 STRESS FRACTURE 1 0.0002
396 BEHAVIOUR DISORDER 1 0.0002
397 PNEUMONITIS 5 0.0002
398 HEART RATE ABNORMAL 1 0.0002
399 PULMONARY OEDEMA 8 0.0002
400 ACUTE PULMONARY OEDEMA 1 0.0002
401 THERAPY NON-RESPONDER 8 0.0002
402 STATUS EPILEPTICUS 2 0.0002
403 ENTEROCOLITIS 1 0.0002
404 BLOOD URIC ACID INCREASED 1 0.0002
405 PAIN IN EXTREMITY 51 0.0002
406 UNINTENTIONAL MEDICAL DEVICE REMOVAL 2 0.0002
407 HYPERKALAEMIA 6 0.0002
408 PROTHROMBIN TIME PROLONGED 1 0.0002
409 INGUINAL HERNIA 1 0.0002
410 ENCEPHALOPATHY 4 0.0002
411 INJECTION SITE EXTRAVASATION 2 0.0002
412 LIVER DISORDER 7 0.0002
413 HYPOTHYROIDISM 5 0.0002
414 ACUTE RESPIRATORY FAILURE 3 0.0002
415 HAEMOGLOBIN ABNORMAL 1 0.0002
416 DIPLOPIA 4 0.0002
417 DEAFNESS 4 0.0002
418 URTICARIA 25 0.0001
419 CONSTIPATION 32 0.0001
420 PAIN 90 0.0001
421 CARDIAC ARREST 12 0.0001
422 RESPIRATION ABNORMAL 1 0.0001
423 VOMITING 68 0.0001
424 HYPOGLYCAEMIA 7 0.0001
425 WEIGHT INCREASED 32 0.0001
426 RIGHT VENTRICULAR FAILURE 1 0.0001
427 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
428 METASTASIS 1 0.0001
429 NEUTROPENIC SEPSIS 1 0.0001
430 LIVER FUNCTION TEST INCREASED 3 0.0001
431 GRAFT VERSUS HOST DISEASE 1 0.0001
432 MYELOSUPPRESSION 5 0.0001
433 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
434 TONGUE DISORDER 1 0.0001
435 FLUID OVERLOAD 2 0.0001
436 RASH MACULO-PAPULAR 3 0.0001
437 OFF LABEL USE 116 0.0001
438 LIPASE INCREASED 1 0.0001
439 HAEMOLYSIS 1 0.0001
440 APNOEA 1 0.0001
441 HYPERTENSION 27 0.0001
442 ANAPHYLACTIC REACTION 7 0.0001
443 COUGH 35 0.0001
444 MIOSIS 1 0.0001
445 SENSORY LOSS 1 0.0001
446 RHINITIS 1 0.0001
447 STAPHYLOCOCCAL INFECTION 4 0.0001
448 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
449 INFUSION RELATED REACTION 8 0.0001
450 FEBRILE NEUTROPENIA 8 0.0001
451 BLOOD PRESSURE DECREASED 8 0.0001
452 EPISTAXIS 9 0.0001
453 PNEUMONIA ASPIRATION 3 0.0001
454 FACIAL PARALYSIS 1 0.0001
455 HAEMATURIA 4 0.0001
456 PRODUCT CONTAINER ISSUE 1 0.0001
457 VISION BLURRED 16 0.0001
458 NEUROPATHY PERIPHERAL 11 0.0001
459 CARDIAC MURMUR 1 0.0001
460 THIRST 2 0.0001
461 HAEMOLYTIC ANAEMIA 1 0.0001
462 OROPHARYNGEAL DISCOMFORT 1 0.0001
463 TREATMENT FAILURE 9 0.0001
464 PERSONALITY CHANGE 1 0.0001
465 ERYTHEMA MULTIFORME 1 0.0001
466 RENAL IMPAIRMENT 9 0.0001
467 NEPHROPATHY 1 0.0001
468 DIARRHOEA HAEMORRHAGIC 1 0.0001
469 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
470 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
471 DEHYDRATION 14 0.0001
472 CHOLESTASIS 2 0.0001
473 DYSSTASIA 3 0.0001
474 BONE PAIN 6 0.0001
475 THERAPY CHANGE 1 0.0001
476 LEUKOPENIA 5 0.0001
477 BRAIN INJURY 1 0.0001
478 CYTOKINE RELEASE SYNDROME 2 0.0001
479 FULL BLOOD COUNT DECREASED 2 0.0001
480 FEEDING DISORDER 2 0.0001
481 EYELID PTOSIS 1 0.0001
482 EAR DISCOMFORT 1 0.0001
483 NEUTROPENIA 13 0.0001
484 TRANSFUSION 1 0.0001
485 BODY HEIGHT DECREASED 1 0.0001
486 HYPOACUSIS 4 0.0001
487 HALLUCINATION 7 0.0001
488 DECREASED ACTIVITY 1 0.0001
489 SEPTIC SHOCK 4 0.0001
490 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
491 ANGIOEDEMA 4 0.0001
492 DECREASED APPETITE 21 0.0001
493 VISUAL ACUITY REDUCED 3 0.0001
494 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
495 NECK PAIN 5 0.0001
496 MALNUTRITION 1 0.0001
497 CARDIAC FAILURE 7 0.0001
498 SPINAL PAIN 1 0.0001
499 MYOCLONUS 1 0.0001
500 IRRITABILITY 5 0.0001
501 PRESYNCOPE 2 0.0001
502 CYTOPENIA 1 0.0001
503 DYSURIA 3 0.0001
504 SMALL INTESTINAL OBSTRUCTION 1 0.0001
505 ILEUS 1 0.0001
506 HEPATIC FUNCTION ABNORMAL 3 0.0001
507 FLUID RETENTION 4 0.0001
508 HEPATIC CYTOLYSIS 1 0.0001
509 ACUTE KIDNEY INJURY 12 0.0001
510 HYPOPHAGIA 2 0.0001
511 DIARRHOEA 50 0.0001
512 CHILLS 9 0.0001
513 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
514 MALAISE 33 0.0001
515 COVID-19 13 0.0001
516 MOOD ALTERED 2 0.0001
517 ACUTE HEPATIC FAILURE 1 0.0001
518 RESPIRATORY ARREST 2 0.0001
519 DEVICE OCCLUSION 1 0.0001
520 BLINDNESS UNILATERAL 1 0.0001
521 LYMPHOPENIA 1 0.0001
522 PARALYSIS 1 0.0001
523 CARDIOGENIC SHOCK 1 0.0001
524 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
525 HAEMOGLOBIN DECREASED 7 0.0001
526 RENAL FAILURE 9 0.0001
527 URINARY INCONTINENCE 2 0.0001
528 STOMATITIS 4 0.0001
529 NAUSEA 52 0.0001
530 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
531 PRODUCT USE ISSUE 12 0.0001
532 DISEASE RECURRENCE 3 0.0001
533 METABOLIC ACIDOSIS 2 0.0001
534 SENSORY DISTURBANCE 1 0.0001
535 INTERSTITIAL LUNG DISEASE 3 0.0001
536 MUSCULAR WEAKNESS 7 0.0001
537 VENTRICULAR TACHYCARDIA 1 0.0001
538 CYTOMEGALOVIRUS INFECTION 1 0.0001
539 VIRAL INFECTION 2 0.0001
540 FUNGAL INFECTION 2 0.0001
541 AGGRESSION 3 0.0001
542 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
543 CHEST PAIN 11 0.0001
544 CANDIDA INFECTION 1 0.0001
545 CIRCULATORY COLLAPSE 1 0.0001
546 PNEUMONIA 19 0.0001
547 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
548 NEUROTOXICITY 1 0.0001
549 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
550 BRADYCARDIA 3 0.0001
551 VISUAL IMPAIRMENT 7 0.0001
552 DRUG ERUPTION 1 0.0001
553 BACK PAIN 13 0.0001
554 CONFUSIONAL STATE 9 0.0001
555 INFECTION 8 0.0001
556 SEPSIS 6 0.0001
557 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
558 EYE PAIN 3 0.0001
559 BLOOD SODIUM DECREASED 1 0.0001
560 COLITIS 2 0.0001
561 LETHARGY 3 0.0001
562 PULMONARY FIBROSIS 1 0.0001
563 DRUG PRESCRIBING ERROR 1 0.0001
564 SEIZURE 6 0.0001
565 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
566 ORAL HERPES 1 0.0001
567 DYSPEPSIA 5 0.0001
568 OEDEMA PERIPHERAL 6 0.0000
569 HYPERSENSITIVITY 9 0.0000
570 ABDOMINAL DISTENSION 5 0.0000
571 HEADACHE 30 0.0000
572 HALLUCINATION, VISUAL 1 0.0000
573 ORAL PAIN 1 0.0000
574 RASH PAPULAR 1 0.0000
575 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
576 OROPHARYNGEAL PAIN 4 0.0000
577 BLOOD PRESSURE FLUCTUATION 1 0.0000
578 SOMNOLENCE 8 0.0000
579 ABDOMINAL PAIN LOWER 1 0.0000
580 HAEMATEMESIS 1 0.0000
581 WEIGHT DECREASED 11 0.0000
582 DRUG RESISTANCE 1 0.0000
583 ANAPHYLACTIC SHOCK 1 0.0000
584 UNRESPONSIVE TO STIMULI 1 0.0000
585 RASH GENERALISED 1 0.0000
586 RESPIRATORY TRACT INFECTION 1 0.0000
587 MUSCULOSKELETAL PAIN 2 0.0000
588 DRUG INTERACTION 6 0.0000
589 JAUNDICE 1 0.0000
590 RASH 16 0.0000
591 GAIT DISTURBANCE 7 0.0000
592 TREATMENT NONCOMPLIANCE 2 0.0000
593 HAEMOPTYSIS 1 0.0000
594 WOUND 1 0.0000
595 RED BLOOD CELL COUNT DECREASED 1 0.0000
596 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
597 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
598 FATIGUE 26 0.0000
599 BLOOD POTASSIUM DECREASED 1 0.0000
600 CORONARY ARTERY DISEASE 1 0.0000
601 EPILEPSY 1 0.0000
602 INJECTION SITE RASH 1 0.0000
603 CARDIAC DISORDER 3 0.0000
604 DRUG-INDUCED LIVER INJURY 1 0.0000
605 RHINORRHOEA 2 0.0000
606 CHOLELITHIASIS 1 0.0000
607 EYE DISORDER 1 0.0000
608 SYNCOPE 3 0.0000
609 NEOPLASM MALIGNANT 2 0.0000
610 ABDOMINAL DISCOMFORT 5 0.0000
611 EYE PRURITUS 1 0.0000
612 ANGER 1 0.0000
613 PRURITUS 11 0.0000
614 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
615 CEREBRAL HAEMORRHAGE 1 0.0000
616 MOBILITY DECREASED 2 0.0000
617 CRYING 1 0.0000
618 EYE SWELLING 1 0.0000
619 HYPOAESTHESIA 4 0.0000
620 INTESTINAL OBSTRUCTION 1 0.0000
621 ARTHRALGIA 11 0.0000
622 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
623 DISORIENTATION 1 0.0000
624 ANXIETY 7 0.0000
625 CARDIO-RESPIRATORY ARREST 1 0.0000
626 URINARY TRACT INFECTION 4 0.0000
627 DRY SKIN 3 0.0000
628 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
629 RENAL DISORDER 1 0.0000
630 MIGRAINE 2 0.0000
631 PRODUCTIVE COUGH 1 0.0000
632 RASH ERYTHEMATOUS 1 0.0000
633 LUNG DISORDER 1 0.0000
634 HEART RATE INCREASED 2 0.0000
635 FLUSHING 2 0.0000
636 THERAPY CESSATION 1 0.0000
637 DYSPNOEA 11 0.0000
638 ILLNESS 2 0.0000
639 INFLAMMATION 1 0.0000
640 ECZEMA 1 0.0000
641 SPEECH DISORDER 1 0.0000
642 DRUG INEFFECTIVE 25 0.0000
643 PANCREATITIS 1 0.0000
644 DEPRESSED MOOD 1 0.0000
645 ASTHENIA 7 0.0000
646 RASH PRURITIC 1 0.0000
647 HAEMATOCHEZIA 1 0.0000
648 INFLUENZA 2 0.0000
649 ASTHMA 2 0.0000
650 DYSPHONIA 1 0.0000
651 NASAL CONGESTION 1 0.0000
652 THERAPEUTIC RESPONSE DECREASED 1 0.0000
653 FEELING HOT 1 0.0000
654 DEEP VEIN THROMBOSIS 1 0.0000
655 PRODUCT DOSE OMISSION 1 0.0000
656 DEATH 13 0.0000
657 HEPATIC ENZYME INCREASED 1 0.0000
658 ABDOMINAL PAIN UPPER 3 0.0000
659 SLEEP DISORDER 1 0.0000
660 AGITATION 1 0.0000
661 DYSGEUSIA 1 0.0000
662 PERIPHERAL SWELLING 2 0.0000
663 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
664 TREMOR 2 0.0000
665 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
666 TOXICITY TO VARIOUS AGENTS 2 0.0000
667 MYALGIA 2 0.0000
668 MYOCARDIAL INFARCTION 2 0.0000
669 GASTROINTESTINAL DISORDER 1 0.0000
670 SWELLING 1 0.0000
671 BLOOD GLUCOSE INCREASED 2 0.0000
672 DYSPHAGIA 1 0.0000
673 DRUG INTOLERANCE 1 0.0000
674 ATRIAL FIBRILLATION 1 0.0000
675 SINUSITIS 1 0.0000
676 FEELING ABNORMAL 2 0.0000
677 JOINT SWELLING 1 0.0000
678 INSOMNIA 2 0.0000
679 CONDITION AGGRAVATED 2 0.0000
680 BLOOD PRESSURE INCREASED 1 0.0000
681 PARAESTHESIA 1 0.0000
682 CEREBROVASCULAR ACCIDENT 1 0.0000
683 NO ADVERSE EVENT 1 0.0000
684 NASOPHARYNGITIS 1 0.0000
685 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
686 ERYTHEMA 1 0.0000
687 OVERDOSE 1 0.0000
688 PRODUCT DOSE OMISSION ISSUE 1 0.0000
689 FALL 1 0.0000
690 DIZZINESS 1 0.0000